Stay updated on ARO-HIF2 in Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the ARO-HIF2 in Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARO-HIF2 in Renal Cell Carcinoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a site update rather than a change to the underlying study details.
    Difference
    0.1%
    Check dated 2026-04-24T06:14:30.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:38:08.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 across the site. No visible content changes were detected.
    Difference
    0.1%
    Check dated 2026-03-19T05:57:04.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T00:51:53.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the page, indicating a minor update. The prior funding-status notice and the previous revision tag 'Revision: v3.4.1' were removed.
    Difference
    0.5%
    Check dated 2026-02-11T14:09:25.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Added a government funding notice about potential delays and operating status, and updated the site revision from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T10:20:30.000Z thumbnail image

Stay in the know with updates to ARO-HIF2 in Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARO-HIF2 in Renal Cell Carcinoma Clinical Trial page.